Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.
about
Gut Microbiota in Cardiovascular Health and Disease.Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.Targeting the Microbiome in Heart Failure.Trimethylamine N-oxide: breathe new life.Gut Microbiota and Atherosclerosis.The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.Safety of betaine as a novel food pursuant to Regulation (EC) No 258/97TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.NMR quantification of trimethylamine-N-oxide in human serum and plasma in the clinical laboratory setting.Relationship between serum trimethylamine N-oxide and exposure to dioxin-like pollutants.Visceral Congestion in Heart Failure: Right Ventricular Dysfunction, Splanchnic Hemodynamics, and the Intestinal Microenvironment.Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.Gut microbiome and its role in cardiovascular diseases.Microbial modulation of cardiovascular disease.Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome.Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk.Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity.Inulin Supplementation Does Not Reduce Plasma Trimethylamine N-Oxide Concentrations in Individuals at Risk for Type 2 Diabetes.
P2860
Q36329055-A04D9EE5-F3F7-46FF-8250-2B402BA62A63Q38637363-6DDB5030-F851-4DA6-9F3C-77C98C720D92Q38701617-18A9A98F-2FE3-4857-98E0-2B88A054841EQ39186198-4CC778EE-CA90-4876-BB93-2CB3243FCCA8Q39459129-CE032FCD-A466-40B0-A7BB-2D7D99E27D3FQ40079055-0B4DAF7E-DFAF-4C51-974A-94603C30F570Q45061812-F31CFC50-4929-4FC7-996A-E84A0CFB041EQ45849451-97377804-EB82-4641-9024-10FB33F163B0Q47161052-B3759C28-73D9-4F64-812F-B47787CD2E4DQ47167057-7A98D095-6A39-499F-84A4-E4E4F106E7C2Q47343299-D986DECC-2AEF-4C36-A150-EC20D1F01FF4Q47651164-4A8A5396-72BA-4120-B7BA-160878BACF73Q50093822-0915EC26-73F7-4CF3-BE9E-14A523FF72B8Q50094276-3E7E17BA-B675-45BA-B9BA-E2C0B166EDB5Q50098251-AF3D206B-1E8E-4650-B0BB-604FDD7081ECQ50144047-AF1FB359-35A0-4E7E-B9B7-679A039604BBQ54247881-CDCF74B7-7481-4686-8C61-186A4211F348Q54302207-EFB62F24-63E6-4C61-BA93-658E284EBB33Q55409994-8A0CA546-22BC-481F-95CA-FE3CE33ECFD3Q55449463-6072DFC0-6F05-47D9-BCFC-2C03F4C6AC03
P2860
Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Increased Trimethylamine N-Oxi ...... with Type 2 Diabetes Mellitus.
@en
Increased Trimethylamine N-Oxi ...... with Type 2 Diabetes Mellitus.
@nl
type
label
Increased Trimethylamine N-Oxi ...... with Type 2 Diabetes Mellitus.
@en
Increased Trimethylamine N-Oxi ...... with Type 2 Diabetes Mellitus.
@nl
prefLabel
Increased Trimethylamine N-Oxi ...... with Type 2 Diabetes Mellitus.
@en
Increased Trimethylamine N-Oxi ...... with Type 2 Diabetes Mellitus.
@nl
P2093
P2860
P1433
P1476
Increased Trimethylamine N-Oxi ...... with Type 2 Diabetes Mellitus.
@en
P2093
Daniel S Li
Stanley L Hazen
W H Wilson Tang
Xinmin S Li
Yiying Fan
P2860
P304
P356
10.1373/CLINCHEM.2016.263640
P407
P50
P577
2016-11-18T00:00:00Z